Skip to main content
Grafa
Health
Zepp Health achieves $63.5 million revenue milestone
Image for illustrative purposes only. Not a real photo.

Zepp Health achieves $63.5 million revenue milestone

Share
  • Zepp Health reported second-quarter 2026 revenue of US$63.5 million, up 6.9% year over year.
  • Gross margin increased to 37.4%, while GAAP net loss widened to US$11.3 million.
  • The company guided third-quarter 2026 revenue to US$68–73 million and continued product expansion plans.

Zepp Health (NYSE:ZEPP) reported second-quarter 2026 revenue of US$63.5 million, up 6.9% year over year, as the company recorded higher gross margins and expanded product activity.

The company’s gross margin increased to 37.4% from the prior-year period, while GAAP net loss attributable to Zepp Health widened to US$11.3 million from US$7.7 million due to foreign-exchange impacts and increased research and marketing expenses.

Zepp Health reported cash and restricted cash of US$106.3 million at June 30, 2026, compared with US$95.3 million a year earlier, while inventory declined and the company converted US$13.3 million of short-term debt into long-term obligations.

The company stated that third-quarter 2026 net revenue is expected to reach US$68–73 million.

Zepp Health develops smart wearable devices and related health technology products, including multiple product families under its consumer electronics business.

The company also announced plans to increase Bip product prices from January 2027, confirmed director Alain Lam’s resignation effective September 1, 2026, and noted the continuation of its up-to-US$20 million share repurchase program.

Frequently asked questions